Remarkable progress in breast cancer treatment has improved patient survival, resulting in
an increased incidence of brain metastasis (BM). Current treatment options for BM are …

The prognosis of breast cancer brain metastasis (BCBM) is extremely poor due to its
resistance to conventional therapy. Elucidation of the molecular mechanisms of BCBM could …

Objective To examine the association between Karnofsky Performance Status (“KPS”) and
brain-specific progression-free survival (“bsPFS”) among patients with breast cancer brain …

Background In Switzerland, approximately 6000 new breast cancer cases and 1300 deaths
are reported annually. Brain metastasis from breast cancer (BMBC) has a major effect on …

Simple Summary Brain metastases (BM) of breast cancer (BC) are new targets of
immunotherapy, but their characteristics are unclear. Therefore, we analyzed the differential …

Purpose The aim of this review was to evaluate the existing evidence for radiotherapy for
brain metastases in breast cancer patients and provide recommendations for the use of …

Introduction: The aim of this study was to assess for clinicopathologic and socioeconomic
features that predict improved survival for patients with advanced breast cancer with …

Background Brain metastasis is an important cause of breast cancer-related death. Aim We
evaluated the relationships between breast cancer subtype and prognosis among patients …

Background Life expectancy for patients diagnosed with metastatic breast cancer (BC) has
improved in recent years, especially due to better systemic treatment. This has led to an …

Purpose We aimed to compare the initial and salvage brain-directed treatment and overall
survival (OS) between patients with 1–4 brain metastases (BMs) and those with 5–10 from …